?? We are honored to announce that the FDA has cleared Eko's Low Ejection Fraction (Low EF) AI. For the first time, U.S. healthcare providers can now detect reduced ejection fraction, a key indicator of heart failure, using an Eko stethoscope during routine physical examinations. ?? Developed in collaboration with Mayo Clinic, Eko's Low EF AI marks a major milestone in the early detection of cardiovascular diseases. ??? Dr. Paul Friedman, Chair of the Department of Cardiovascular Medicine at Mayo Clinic in Rochester, remarked: "The ability to identify a hidden, potentially life-threatening heart condition using a tool that primary care and subspecialist clinicians are familiar with — the stethoscope — can help us prevent hospitalizations and adverse events. Importantly, since a stethoscope is small and portable, this technology can be used in urban and remote locations and hopefully help address care in underserved areas." ??? Connor Landgraf, co-founder and CEO of Eko Health, highlighted: "The stethoscope, the most recognizable symbol of healthcare, touches the lives of an estimated 1 billion people around the globe every year. With Eko's Low EF AI, we've transformed the icon of medicine into an AI-powered heart failure early detection tool that can help improve access to care for millions of patients at a fraction of the time and cost of echocardiography. It's been a privilege to work alongside Mayo Clinic in this groundbreaking endeavor." ?? Read the full press release here: https://lnkd.in/g6wur3Xb #healthcare #digitalhealth #AI #cardiology #health
Eko Health
医疗设备制造业
Emeryville,California 15,514 位关注者
Eko Health is a leader in AI technology for heart and lung disease detection. Early Detection is Primary.
关于我们
Eko Health, Inc. (Eko) is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes and AI detection platform, SENSORA?. The company’s FDA-cleared technologies are used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others.
- 网站
-
https://www.ekosensora.com/
Eko Health的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 51-200 人
- 总部
- Emeryville,California
- 类型
- 私人持股
- 创立
- 2013
- 领域
- artificial intelligence、machine learning、digital health、telehealth、telemedicine、stethoscope、physical exam、medical device、healthcare technology、cardiovascular disease、heart disease、lung disease和SENSORA?
地点
-
主要
2100 Powell St
Suite 300
US,California,Emeryville,94608
Eko Health员工
动态
-
?? When a Heartbeat is More Than Just a Sound After decades of battling heart complications, Bob Betcher received the ultimate gift — a new heart. But his story didn’t end there. Using the Eko CORE 500? Digital Stethoscope, Bob shared something extraordinary with his donor’s family: the sound and rhythm of their son’s heartbeat. In an emotional moment, the donor’s parents listened to their son's heart beating once more, now within Bob. Through the Eko App, they not only heard the heartbeat but saw its rhythm come alive, creating a connection beyond words. This isn’t just about technology — it’s about healing, gratitude, and the power of a heartbeat to unite lives. Read Bob’s full story of resilience and connection: https://bit.ly/4fGYNs7
Eko Health | CORE 500 ? Helps Heart Recipient Connect with Donor's Family
ekohealth.com
-
We're live at the American Heart Association (AHA) Scientific Sessions 2024! Meet us at booth #1809 to learn how Eko’s software, combined with advanced digital stethoscope technology, can help you detect disease earlier. #AHA2024 #AmericanHeartAssociation #Cardiology #SENSORA #AHA24 Hilal Demir Dean Bowerman Grace Hanson Joe Tertel Michaela Landgraf
-
Meet us tomorrow at the American Heart Association (AHA) Scientific Sessions 2024 at booth #1809 to learn how Eko’s software, combined with advanced digital stethoscope technology, can help you detect disease earlier. Schedule a meeting with the Eko team today: https://lnkd.in/gbdefyfx #AHA2024 #AmericanHeartAssociation #Cardiology #SENSORA #AHA24
-
Our work is not done. Eko's goal is to arm all 26 million healthcare professionals who use a stethoscope today with advanced heart disease detection capabilities so they can diagnose earlier and treat faster before complications become more significant. Securing an avenue for billing and reimbursement is a big part of the journey.
The American Medical Association approved Eko Health's application for a Category III CPT code, establishing a common nomenclature for our AI-enabled cardiac disease detection software that insurance can choose to cover and healthcare providers can choose to use starting in July. It has been an honor to steward this market access initiative, with gratitude to Connor Landgraf and Jason Bellet for the trust. Heart disease remains the leading cause of mortality in the United States, accounting for about 1 in every 5 deaths. Early detection plays a critical role in improving patient outcomes. By empowering primary care providers to identify cardiac issues earlier, Eko AI assists clinicians in detecting cardiac disease signs often missed by standard care. https://lnkd.in/g_aMPJ9m
Eko Health Granted Category III CPT Code for SENSORA
ekohealth.com
-
Today, Eko Health is proud to announce that the American Medical Association has issued a Category III CPT code for our SENSORA? Cardiac Early Detection Platform, effective July 1, 2025. This milestone paves the way for potential reimbursement, empowering clinicians nationwide to integrate AI-driven heart disease detection into frontline care. SENSORA? uses FDA-cleared algorithms to identify critical signs of heart disease, including murmurs, low ejection fraction (Low EF), and arrhythmias like atrial fibrillation (AFib). Heart disease is the leading cause of death in the U.S., and early detection is vital for improving patient outcomes. By empowering primary care providers to identify cardiac issues earlier, SENSORA? enhances proactive care and reduces the burden of advanced heart disease management. "The AMA’s creation of Category III CPT code for Eko’s AI disease detection algorithms is a major step in increasing access to early heart disease detection," said Connor Landgraf, CEO of Eko Health. "This milestone will help enable clinicians to use powerful, validated tools to identify heart disease early, ultimately improving patient outcomes, especially in communities with limited access to specialist care." ?? Read the full press release: https://lnkd.in/djS_C6bG
Eko Health Granted Category III CPT Code for SENSORA
ekohealth.com
-
This Veterans Day, we honor the healthcare heroes who serve those who’ve sacrificed for our freedom. ?? This year, Eko partnered with the Best Defense Foundation, donating 13 CORE 500? Digital Stethoscopes to support their medical team during a profound journey to Normandy for the 80th anniversary of D-Day. The advanced cardiac care ensured these heroes could revisit their history with confidence and care. Today, and every day, we stand with those who dedicate themselves to delivering better outcomes and brighter futures for our veterans. ?? Read the full story: https://bit.ly/4hG38Np #VeteransDay #HonoringHeroes #EkoHealth #BestDefenseFoundation
Eko Health | Eko Supports Military Heroes Through the Best Defense Foundation
ekohealth.com
-
Join the Eko Health team during the American Heart Association (AHA) Scientific Sessions 2024 at booth #1809 to learn how Eko’s software, combined with advanced digital stethoscope technology, can help you detect disease earlier. Schedule a meeting with the Eko team today: https://lnkd.in/gg6ZKaUy #AHA2024 #AmericanHeartAssociation #Cardiology #SENSORA #AHA24
此处无法显示此内容
在领英 APP 中访问此内容等
-
?? We’re proud to announce Carrie Redick RN MSN NEA-BC from Atlantic Health System as our October SENSORA? Heart Hero! ?? Carrie Redick drives Atlantic Health System’s Interventional Cardiology Programs across six hospitals, transforming patient care and operational efficiency in Cardiac Catheterization Labs, Electrophysiology Labs, and the Structural Heart Program. Her leadership has doubled the Structural Heart Program's TAVR contribution margin through optimized care pathways and digital solutions, earning Morristown Medical Center ACC accreditation in 2020 and 2023. She also introduced SENSORA? exams for at-risk patients, advancing cardiac care across Atlantic Health. With 18 years as a bedside nurse, Carrie’s blend of clinical expertise and strategic vision is a powerful asset, directly elevating patient care and program success. Thank you for being a true Heart Hero and setting the bar high for excellence in cardiac care. #HeartHeroes #SENSORA #QualityCare #AI #CardiacCare #Innovation #EarlyDetection #HeartHealth #HealthcareExcellence
-
?? “SENSORA? saved my life.” This powerful testimonial highlights a life-changing journey where early detection through Eko’s SENSORA? Cardiac Disease Detection Platform made all the difference. SENSORA? empowers healthcare providers with the precision needed to detect heart conditions sooner, helping them act quickly and potentially save lives. Learn more about how SENSORA? is transforming heart health and early detection. Contact us: https://lnkd.in/gkzWndnC #HeartHealth #InnovationInCare #PatientStories #SENSORA #CardiacCare